Zydus Cadila gets USFDA approval for generic cancer drug

Zydus Cadila gets USFDA approval for generic cancer drug

PTIUpdated: Friday, June 25, 2021, 11:44 AM IST
article-image
Zydus Cadila had earlier in October 2020 received approval to market the Fingolimod capsules in the strength of .5mg | File photo

Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market Pemetrexed injection, used to treat certain kinds of cancers, in the American market.

The Ahmedabad-based drug maker has received approval from the US Food and Drug Administration (USFDA) for the injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials, Zydus Cadila said in a statement.

Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

The drug will be manufactured at the formulation manufacturing facility at Ahmedabad, the drug maker noted.

The group now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04, it added.

Zydus Cadila discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs nearly 25,000 people worldwide.

Cadila Healthcare is the group's listed entity.

RECENT STORIES

Banks To Stay Open On Sunday: Upon Government Request, RBI Asks Lenders To Function On March 31

Banks To Stay Open On Sunday: Upon Government Request, RBI Asks Lenders  To Function On March 31

Stock Market News: Indian Indices To Remain Shut Today On Account Of Good Friday

Stock Market News: Indian Indices To Remain Shut Today On Account Of Good Friday

How Does SIP Help You Create Wealth in the Long Term?

How Does SIP Help You Create Wealth in the Long Term?

The Disruptive Potential of AI in Stock Market Trading: Rohan Menon's Perspective

The Disruptive Potential of AI in Stock Market Trading: Rohan Menon's Perspective

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?